A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. (Q51768835)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2008
edit
Language Label Description Also known as
English
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
scientific article published in February 2008

    Statements

    A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit